Cargando…

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement

Detalles Bibliográficos
Autores principales:	Watanabe, Eri, Chen, Yucheng, Neilan, Tomas G, Ho, Carolyn, Shah, Ravi, Blankstein, Ron, Jerosch-Herold, Michael, Kwong, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305277/ http://dx.doi.org/10.1186/1532-429X-14-S1-O98

Ejemplares similares

Quantitative T1 mapping and the fibrotic index in normal healthy volunteers; relationship to aging and cardiac dimensions
por: Neilan, Tomas G, et al.
Publicado: (2012)

T1 measurements identify extracellular volume expansion in a genotyped hypertrophic cardiomyopathy population with and without left ventricular hypertrophy
por: Abbasi, Siddique, et al.
Publicado: (2013)

Feasibility and prognostic value of stress-perfusion CMR in obesity
por: Shah, Ravi, et al.
Publicado: (2012)

Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy
por: Chen, Yucheng, et al.
Publicado: (2012)

Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events
por: Coelho-Filho, Otavio, et al.
Publicado: (2011)

Myocardial extracellular volume expansion in patients with hypertension
por: Neilan, Tomas G, et al.
Publicado: (2013)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
por: Smith, Brandon M, et al.
Publicado: (2013)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Identification of myocardial extracellular matrix expansion by cardiac MRI in hypertensive patients
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
por: Morita, Yusuke, et al.
Publicado: (2014)

A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
por: Flett, Andrew, et al.
Publicado: (2013)

The incidence and prognostic value of silent myocardial scar by late gadolinium enhancement in patients with atrial fibrillation
por: Neilan, Tomas G, et al.
Publicado: (2013)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

CMR quantification of infarct tissue heterogeneity and remote myocardial fibrotic burden during convalescent phase following acute myocardial infarction (MI) provided strong and complementary evidence of ventricular arrhythmogenicity from quantitative microvolt T-wave alternans testing (the NHLBI PROSPECT-CMR study)
por: Heydari, Bobby, et al.
Publicado: (2012)

Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with suspected myocardial ischemia
por: Steel, Kevin, et al.
Publicado: (2009)

Left atrial volume during the early convalescent phase of acute MI is strongly related to expansion of myocardial extracellular matrix during infarct healing and ventricular remodeling
por: Farhad, Hoshang, et al.
Publicado: (2013)

Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy
por: Zhang, Qiang, et al.
Publicado: (2021)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
por: Dass, Sairia, et al.
Publicado: (2012)

ST2 is reduced by high-dose omega-3 fatty acid treatment following acute MI and is correlated with reduction of the extracellular volume fraction of non-infarcted myocardium
por: Heydari, Bobby, et al.
Publicado: (2016)

Myocardial Extracellular Matrix Volume has independent prognostic value in patients with non-ischemic cardiomyopathy
por: Vita, Tomas S, et al.
Publicado: (2016)

Infarct tissue heterogeneity by contrast-enhanced MRI is a novel predictor of mortality in patients with coronary artery disease with reduced left ventricular systolic function
por: Watanabe, Eri, et al.
Publicado: (2011)

Left ventricular mass by cardiac magnetic resonance imaging and adverse cardiovascular outcomes in patients treated with anthracycline-based chemotherapy
por: Neilan, Tomas G, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Risk stratification by regadenoson stress MRI in patients with known or suspected coronary artery disease
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Diabetics without prior cardiovascular disease have diffuse interstitial fibrosis by CMR independent of clinical risk factors
por: Shah, Ravi, et al.
Publicado: (2012)

Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy
por: Hughes, Rebecca K., et al.
Publicado: (2023)

Effect of purified omega-3 fatty acids on reducing left ventricular remodeling after acute myocardial infarction (OMEGA-REMODEL study): a double-blind randomized clinical trial)
por: Heydari, Bobby, et al.
Publicado: (2015)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Apical Hypertrophic Cardiomyopathy: A Case Report
por: Abugroun, Ashraf, et al.
Publicado: (2017)

Apical Hypertrophic Cardiomyopathy: The Variant Less Known
por: Hughes, Rebecca K., et al.
Publicado: (2020)

Apical Hypertrophic Cardiomyopathy Masked by Takotsubo Syndrome
por: Gherbesi, Elisa, et al.
Publicado: (2020)

Myocardial strain imaging with radial acquisitions (SIRA) reduces tag fading compared to Cartesian sampling
por: Hulten, Edward, et al.
Publicado: (2014)

Pacemaker Treatment for Apical Hypertrophic Cardiomyopathy in the Setting of an Apical Ventricular Aneurysm
por: Toyoda, Shigeru, et al.
Publicado: (2021)

Thrombosis Formation in the Apical Aneurysm of a Patient with Apical Hypertrophic Cardiomyopathy
por: Hosseinsabet, Ali
Publicado: (2021)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
por: Rodriguez-Granillo, Gaston A., et al.
Publicado: (2016)

Diabetes remains an independent risk factor for adverse remodeling following acute myocardial infarction even with quantification of total infarct size and change in myocardial extracellular volume fraction by CMR
por: Heydari, Bobby, et al.
Publicado: (2013)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

First-pass stress perfusion MR Imaging findings of apical hypertrophic cardiomyopathy: with relation to LV wall thickness and late Gadolinium-enhancement
por: Yoo, Jin Young, et al.
Publicado: (2015)

Apical hypertrophic cardiomyopathy with apical endomyocardial fibrosis and calcification: Two case reports
por: Huang, Weiliang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_urvdt2sk82clt4hlo16m15e6ep